Clinical trial
Comparative Effectiveness of Sentinel Lymph Node Biopsy (SLNB) for Ductal Carcinoma In Situ (DCIS)
NCT02908178 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Effectiveness of Sentinel Lymph Node Biopsy (SLNB) for Ductal Carcinoma In Situ (DCIS)
- Lead sponsor
- Yale University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 25, 2017
- Completion date
- June 29, 2018
- Enrollment
- 28,291 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ductal carcinoma in situ